These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7608489)

  • 21. Cryoglobulinemia with vasculitis associated with hepatitis C virus infection.
    Marcellin P; Descamps V; Martinot-Peignoux M; Larzul D; Xu L; Boyer N; Pham BN; Crickx B; Guillevin L; Belaich S
    Gastroenterology; 1993 Jan; 104(1):272-7. PubMed ID: 8380394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
    Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
    Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
    N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin M antibody to hepatitis C virus during interferon therapy for chronic hepatitis C.
    Quiroga JA; Bosch O; Gonzalez R; Marriott E; Castillo I; Bartolome J; Carreño V
    Gastroenterology; 1992 Oct; 103(4):1285-9. PubMed ID: 1383071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis C].
    Viola LA; Fernández JL
    Acta Gastroenterol Latinoam; 1992; 22(2):133-4. PubMed ID: 1338677
    [No Abstract]   [Full Text] [Related]  

  • 26. Virological and biochemical responses to interferon-alpha in chronic hepatitis C.
    Picciotto A; Bardellini E; Borzone S; Sinelli N; Bonanni P; Bruzzone B; Icardi GC; Celle G
    Lancet; 1994 Jan; 343(8888):54-5. PubMed ID: 7905064
    [No Abstract]   [Full Text] [Related]  

  • 27. Are hepatitis C virus antibodies involved in chronic liver diseases other than non-A, non-B hepatitis?
    Viola L; Pimentel E; Morgante P; Fernández JL
    Hepatology; 1991 Dec; 14(6):1303-4. PubMed ID: 1660023
    [No Abstract]   [Full Text] [Related]  

  • 28. [Trend of anti HCV titer in interferon treatment of chronic hepatitis C].
    Kumada H
    Nihon Rinsho; 1991 Feb; 49(2):451-9. PubMed ID: 1849208
    [No Abstract]   [Full Text] [Related]  

  • 29. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two cases of porphyria cutanea tarda associated with chronic hepatitis positive for the antibody against hepatitis C virus.
    Kanno A; Amakasu H; Torinuki W; Yamamoto T; Ishii M; Numata N; Ohori H
    Tohoku J Exp Med; 1994 Jan; 172(1):83-90. PubMed ID: 7913558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The A to F of viral hepatitis.
    Lancet; 1990 Nov; 336(8724):1158-60. PubMed ID: 1978030
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy.
    Yuki N; Hayashi N; Hagiwara H; Takehara T; Katayama K; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1993 Jun; 17(6):960-5. PubMed ID: 7685734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow up of blood donors positive for antibodies to hepatitis C virus.
    Ryan KE; MacLennan S; Barbara JA; Hewitt PE
    BMJ; 1994 Mar; 308(6930):696-7. PubMed ID: 8068079
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of chronic hepatitis C with recombinant human interferon-alpha 2a: results of a randomized controlled clinical trial.
    Diodati G; Bonetti P; Noventa F; Casarin C; Rugge M; Scaccabarozzi S; Tagger A; Pollice L; Tremolada F; Davite C
    Hepatology; 1994 Jan; 19(1):1-5. PubMed ID: 7506223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basal core-IgM antibodies to hepatitis C virus are not predictive of successful alpha-interferon therapy.
    Caporaso N; Tuccillo C; Morisco F
    J Hepatol; 1995 Mar; 22(3):377. PubMed ID: 7608491
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis C virus antibody titration in patients with chronic hepatitis C, before and after interferon treatment.
    Takahashi M; Yamada G; Miyamoto R; Doi T; Endo H; Nishimoto H; Fujiki S; Shimomura H; Mizuno M; Tsuji T
    Acta Med Okayama; 1992 Oct; 46(5):331-6. PubMed ID: 1279945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus antibodies in patients on hemodialysis and after kidney transplantation.
    Ponz E; Campistol JM; Barrera JM; Gil C; Pinto J; Andreu J; Bruguera M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1371-2. PubMed ID: 1846466
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
    Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
    Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of early interferon alfa therapy for hepatitis C virus infection recurrence after liver transplantation.
    Boillot O; Berger F; Rasolofo E; Mion F; Chevallier P; Gille D; Paliard P
    Transplant Proc; 1995 Aug; 27(4):2501. PubMed ID: 7544508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.